Aoife Brennan - Dissemin

Language
Login

All papers authored by Aoife Brennan

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2023 Jason J. Luke, Sarina A. Piha Paul

ORCID

, Theresa Medina, Claire F. Verschraegen, Mary Varterasian, Aoife M. Brennan

ORCID

, Richard J. Riese, Anna Sokolovska, James Strauss, David L. Hava, Filip Janku

Supplementary Figure S5 from Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Jason J. Luke, Sarina A. Piha Paul

ORCID

, Theresa Medina, Claire F. Verschraegen, Mary Varterasian, Aoife M. Brennan

ORCID

, Richard J. Riese, Anna Sokolovska, James Strauss, David L. Hava, Filip Janku

Supplementary Figure S7 from Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Jason J. Luke, Sarina A. Piha Paul

ORCID

, Theresa Medina, Claire F. Verschraegen, Mary Varterasian, Aoife M. Brennan

ORCID

, Richard J. Riese, Anna Sokolovska, James Strauss, David L. Hava, Filip Janku

Supplementary Figure S6 from Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Jason J. Luke, Sarina A. Piha Paul

ORCID

, Theresa Medina, Claire F. Verschraegen, Mary Varterasian, Aoife M. Brennan

ORCID

, Richard J. Riese, Anna Sokolovska, James Strauss, David L. Hava, Filip Janku

Supplementary Figure S4 from Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Jason J. Luke, Sarina A. Piha Paul

ORCID

, Theresa Medina, Claire F. Verschraegen, Mary Varterasian, Aoife M. Brennan

ORCID

, Richard J. Riese, Anna Sokolovska, James Strauss, David L. Hava, Filip Janku

Supplementary Table S2 from Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Jason J. Luke, Sarina A. Piha Paul

ORCID

, Theresa Medina, Claire F. Verschraegen, Mary Varterasian, Aoife M. Brennan

ORCID

, Richard J. Riese, Anna Sokolovska, James Strauss, David L. Hava, Filip Janku

Supplementary Figure S1 from Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Jason J. Luke, Sarina A. Piha Paul

ORCID

, Theresa Medina, Claire F. Verschraegen, Mary Varterasian, Aoife M. Brennan

ORCID

, Richard J. Riese, Anna Sokolovska, James Strauss, David L. Hava, Filip Janku

Data from Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Jason J. Luke, Sarina A. Piha Paul

ORCID

, Theresa Medina, Claire F. Verschraegen, Mary Varterasian, Aoife M. Brennan

ORCID

, Richard J. Riese, Anna Sokolovska, James Strauss, David L. Hava, Filip Janku

Supplementary Figure S3 from Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Jason J. Luke, Sarina A. Piha Paul

ORCID

, Theresa Medina, Claire F. Verschraegen, Mary Varterasian, Aoife M. Brennan

ORCID

, Richard J. Riese, Anna Sokolovska, James Strauss, David L. Hava, Filip Janku

Supplementary Figure S2 from Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Jason J. Luke, Sarina A. Piha Paul

ORCID

, Theresa Medina, Claire F. Verschraegen, Mary Varterasian, Aoife M. Brennan

ORCID

, Richard J. Riese, Anna Sokolovska, James Strauss, David L. Hava, Filip Janku

Supplementary Table S1 from Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Jason J. Luke, Sarina A. Piha Paul

ORCID

, Theresa Medina, Claire F. Verschraegen, Mary Varterasian, Aoife M. Brennan

ORCID

, Richard J. Riese, Anna Sokolovska, James Strauss, David L. Hava, Filip Janku

Supplementary Figure S8 from Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies

Upload

This paper is made freely available by the publisher.

2022 Aoife M. Brennan

ORCID

Development of synthetic biotics as treatment for human diseases

Download from academic.oup.com

Missing publications? Search for publications with a matching author name.